Prevalence and Risk Factors of Stroke in Inpatients with Type 2 Diabetes Mellitus in China

Overview

Journal Curr Med Sci

Specialty General Medicine

Date 2024 Jul 22

PMID 39039375

Authors

Zuo-Ling Xie

Chen-Chen Wang

Xi Huang

Zheng Wang

Hai-Yan Shangguan

Shao-Hua Wang

Affiliations

Soon will be listed here.

Abstract

Objective: The prevalence and the cluster characteristics of risk factors of stroke were assessed in a Chinese diabetic population.

Methods: Clinical data of 30 693 inpatients who were diagnosed with type 2 diabetes mellitus (T2DM) and admitted between 2013 and 2018 were retrospectively analyzed. The age-standardized prevalence of stroke was estimated using the 2010 Chinese population census data, and risk factors were analyzed by multiple imputation and regression.

Results: The crude and standardized prevalence rates of stroke in patients with T2DM were 34.4% and 21.5%, respectively, and 85.2% of the stroke patients had ischemic stroke. Nearly half of the patients who experienced stroke had clusters of more than 4 risk factors. Compared with no-risk-factor clustering, the risk of stroke significantly increased 3-4 times in the presence of more than 4 risk-factor clusters (P<0.001). Hypertension was the most common major risk factor for ischemic stroke [odds ratio (OR), 2.34; 95% confidence interval (CI), 2.18-2.50] and hemorrhagic stroke (OR, 3.68; 95% CI 2.95-4.59; P<0.001). Moreover, a 1-standard-deviation increase in fasting blood glucose (FBG) was significantly negatively correlated with ischemic stroke risk, and the same change in FBG was significantly associated with an 8% increased risk of hemorrhagic stroke.

Conclusion: The prevalence of stroke in patients with T2DM is rather high, and the clustering of risk factors is associated with the development of stroke in T2DM patients. Risk factors differ in different stroke subtypes. Identifying risk factors for a specific high-risk group is necessary.

References

Bragg F, Holmes M, Iona A, Guo Y, Du H, Chen Y . Association Between Diabetes and Cause-Specific Mortality in Rural and Urban Areas of China. JAMA. 2017; 317(3):280-289. PMC: 6520233. DOI: 10.1001/jama.2016.19720. View

Fox C, Coady S, Sorlie P, DAgostino Sr R, Pencina M, Vasan R . Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study. Circulation. 2007; 115(12):1544-50. DOI: 10.1161/CIRCULATIONAHA.106.658948. View

ODonnell M, Chin S, Rangarajan S, Xavier D, Liu L, Zhang H . Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. 2016; 388(10046):761-75. DOI: 10.1016/S0140-6736(16)30506-2. View

Zhou M, Wang H, Zhu J, Chen W, Wang L, Liu S . Cause-specific mortality for 240 causes in China during 1990-2013: a systematic subnational analysis for the Global Burden of Disease Study 2013. Lancet. 2015; 387(10015):251-72. DOI: 10.1016/S0140-6736(15)00551-6. View

Morren J, Salgado E . Prevalence and control of stroke risk factors in a South Florida population. Int J Neurosci. 2012; 122(12):734-41. DOI: 10.3109/00207454.2012.721410. View

Shaheen H, Abdel Wahed W, Hasaneen S . Prevalence of Stroke in Fayoum Governorate, Egypt: A Community-Based Study. J Stroke Cerebrovasc Dis. 2019; 28(9):2414-2420. DOI: 10.1016/j.jstrokecerebrovasdis.2019.06.031. View

Susmitha K, Chandrasekhar V, Kiran G, Divya A, Rani G, Sarangapani M . Prevalence of Stroke Cases in Warangal, Telangana Region, India: A Hospital-Based Case Study. Adv Exp Med Biol. 2020; 1196:109-115. DOI: 10.1007/978-3-030-32637-1_11. View

Al-Ozairi E, Jallo M, Hafidh K, Alhajeri D, Ashour T, Mahmoud E . Prevalence of Cardiovascular and Renal Co-morbidities in Patients with Type 2 Diabetes in the Gulf, a Cross-sectional Observational Study. Diabetes Ther. 2021; 12(4):1193-1207. PMC: 7994503. DOI: 10.1007/s13300-021-01038-6. View

Lee C, Wu Y, Kuo J, Chen J, Chin M, Hung Y . Prevalence of diabetic macrovascular complications and related factors from 2005 to 2014 in Taiwan: A nationwide survey. J Formos Med Assoc. 2019; 118 Suppl 2:S96-S102. DOI: 10.1016/j.jfma.2019.08.035. View

10.

Zhao D, Liu J, Wang W, Zeng Z, Cheng J, Liu J . Epidemiological transition of stroke in China: twenty-one-year observational study from the Sino-MONICA-Beijing Project. Stroke. 2008; 39(6):1668-74. DOI: 10.1161/STROKEAHA.107.502807. View

11.

Lyu Y, Luo Y, Li C, Guo X, Lu J, Wu H . Regional Differences in the Prevalence of Coronary Heart Disease and Stroke in Patients With Type 2 Diabetes in China. J Clin Endocrinol Metab. 2018; 103(9):3319-3330. DOI: 10.1210/jc.2018-00422. View

12.

Stollova M, Schuck O, Smrckova I, Skibova J, Teplan V . The auxiliary table for GFR estimation according to the MDRD formula. J Ren Care. 2008; 34(1):43-4. DOI: 10.1111/j.1755-6686.2008.00010.x. View

13.

Li Y, Teng D, Shi X, Qin G, Qin Y, Quan H . Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study. BMJ. 2020; 369:m997. PMC: 7186854. DOI: 10.1136/bmj.m997. View

14.

Wang W, Jiang B, Sun H, Ru X, Sun D, Wang L . Prevalence, Incidence, and Mortality of Stroke in China: Results from a Nationwide Population-Based Survey of 480 687 Adults. Circulation. 2017; 135(8):759-771. DOI: 10.1161/CIRCULATIONAHA.116.025250. View

15.

Li Y, Yang L, Wang L, Zhang M, Huang Z, Deng Q . Burden of hypertension in China: A nationally representative survey of 174,621 adults. Int J Cardiol. 2016; 227:516-523. DOI: 10.1016/j.ijcard.2016.10.110. View

16.

Yusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P . Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet. 2019; 395(10226):795-808. PMC: 8006904. DOI: 10.1016/S0140-6736(19)32008-2. View

17.

Mertens B, Banzato E, de Wreede L . Construction and assessment of prediction rules for binary outcome in the presence of missing predictor data using multiple imputation and cross-validation: Methodological approach and data-based evaluation. Biom J. 2020; 62(3):724-741. PMC: 7217034. DOI: 10.1002/bimj.201800289. View

18.

Feigin V, Lawes C, Bennett D, Anderson C . Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol. 2003; 2(1):43-53. DOI: 10.1016/s1474-4422(03)00266-7. View

19.

Sivenius J, Tuomilehto J, Immonen-Raiha P, Kaarisalo M, Sarti C, Torppa J . Continuous 15-year decrease in incidence and mortality of stroke in Finland: the FINSTROKE study. Stroke. 2004; 35(2):420-5. DOI: 10.1161/01.STR.0000110220.63212.59. View

20.

Heuschmann P, Grieve A, Toschke A, Rudd A, Wolfe C . Ethnic group disparities in 10-year trends in stroke incidence and vascular risk factors: the South London Stroke Register (SLSR). Stroke. 2008; 39(8):2204-10. DOI: 10.1161/STROKEAHA.107.507285. View